Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 473–473 | Cite as

Trastuzumab emtansine

Transaminitis and regenerative hepatic nodules during off-label use: case report
Case report
  • 11 Downloads

Reference

  1. Gottesdiener LS, et al. Rates of ErbB2 alterations across melanoma subtypes and a complete response to trastuzumab emtansine in an ErbB2-amplified acral melanoma. Clinical Cancer Research 24: 5815-5819, No. 23, Dec 2018. Available from: URL: http://doi.org/10.1158/1078-0432.CCR-18-1397 - USACrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations